References
- Hicks R J, MacManus M P, Seymour J F. Initial staging of lymphoma with positron emission tomography and computed tomography. Semin Nucl Med 2005; 35(3)165–175
- Shah N, Hoskin P, McMillan A, Gibson P, Lowe J, Wong W L. The impact of FDG positron emission tomography imaging on the management of lymphomas. Br J Radiol 2000; 73(869)482–487
- Blum R H, Seymour J F, Wirth A, MacManus M, Hicks R J. Frequent impact of [18F]fluorodeoxyglucose positron emission tomography on the staging and management of patients with indolent non-Hodgkin's lymphoma. Clin Lymphoma 2003; 4: 43–49
- Hoffmann M, Kletter K, Diemling M, Becherer A, Pfeffel F, Petkov V, et al. Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type. Ann Oncol 1999; 10: 1185–1189
- Israel O, Keidar Z, Bar-Shalom R. Positron emission tomography in the evaluation of lymphoma. Semin Nucl Med 2004; 34: 166–179
- Alinari L, Castellucci P, Elstrom R, Ambrosini V, Stefoni V, Nanni C, et al. 18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. Leuk Lymphoma 2006; 47: 2096–2101
- Beal K P, Yeung H W, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 2005; 16: 473–480
- Di Chiro G, DeLaPaz R L, Brooks R A, Sokoloff L, Kornblith P L, Smith B H, et al. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 1982; 32: 1323–1329
- Patronas N J, Di Chiro G, Kufta C, Bairamian D, Kornblith P L, Simon R, et al. Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 1985; 62: 816–822
- Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi Y E, et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol 2005; 23: 4643–4651
- Wohrer S, Jaeger U, Kletter K, Becherer A, Hauswirth A, Turetschek K, et al. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading. Ann Oncol 2006; 17: 780–784
- Isaacson P, Wright D H. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410–1416
- Hoffmann M, Kletter K, Becherer A, Jager U, Chott A, Raderer M. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 2003; 64: 336–340
- Zhuang H, Pourdehnad M, Lambright E S, Yamamoto A J, Lanuti M, Li P, et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42: 1412–1417